Results 21 to 30 of about 28,214,434 (299)
Cost-effectiveness analysis of COVID-19 vaccination in Poland
Archives of Medical Science, 2021 Introduction The aim of our study was to assess the potential value of the Comirnaty vaccine (BNT162b2) in Poland. A model was used to estimate patient events, direct medical costs, utilities, and cost-effectiveness for 1 year with and without ...
Katarzyna Orlewska +2 more
doaj +1 more source
Cost-effectiveness analysis results.
, 2022 Cost-effectiveness analysis results.
Mihaela Nica (3357893) +5 more
core +1 more source
A guide to cost-effectiveness acceptability curves [PDF]
, 2005 Use of cost-effectiveness acceptability curves, as a method for summarising information on uncertainty in cost-effectiveness, has become widespread within applied studies. This includes several studies in the mental health field.
Byford, S. +3 more
core +1 more source
A Cost-Effectiveness Analysis of the Integration of Robotic Spine Technology in Spine Surgery [PDF]
Neurospine, 2018 Objective We investigate the cost-effectiveness of adding robotic technology in spine surgery to an active neurosurgical practice. Methods The time of operative procedures, infection rates, revision rates, length of stay, and possible conversion of open ...
Richard Philip Menger +3 more
doaj +1 more source
, 2017 Economic evaluation of healthcare programs seeks to compare treatments and preventive measures in terms of their efficiency, that is, their ability to generate health and well-being relative to the costs incurred. This chapter provides an introduction to one particular but widely used evaluation technique: cost-effectiveness analysis (CEA).
Luyten, Jeroen, Henderson, Cate
openaire +3 more sources
COST‐MINIMISATION ANALYSIS VERSUS COST‐EFFECTIVENESS ANALYSIS, REVISITED
Health Economics, 2011 ABSTRACT We aim to establish whether it is ever appropriate to conduct cost‐minimisation analysis (CMA) rather than cost‐effectiveness analysis.We perform a literature review to examine how the use of CMA has changed since Briggs & O'Brien announced its death in 2001.
Dakin, H, Wordsworth, S
openaire +5 more sources
QALY league table of Iran: a practical method for better resource allocation
Cost Effectiveness and Resource Allocation, 2021 Background The limited health care resources cannot meet all the demands of the society. Thus, decision makers have to choose feasible interventions and reject the others. We aimed to collect and summarize the results of all cost utility analysis studies
Reza Hashempour +4 more
doaj +1 more source
Cost-effectiveness in clinical trials : using multiple imputation to deal with incomplete cost data [PDF]
, 2007 Background: Cost-effectiveness has become an important outcome in many clinical trials and has resulted in the collection of resource use data and the calculation of costs for individual patients.
Burton, Andrea +4 more
core +1 more source
Journal of Pharmacoeconomics and Pharmaceutical Management, 2023 Background Hypertension is a chronic disease that cannot be cured and can only be controlled but requires long-term treatment, even for life. The variety of antihypertensive treatments makes it necessary to adjust the choice of treatment not only in ...
Ida Adhayanti +2 more
doaj +1 more source
The death of cost-minimization analysis? [PDF]
, 2001 Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by
Bernie J. O'Brien +3 more
core +1 more source